share_log

Alliance Global Partners Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

Benzinga ·  May 24, 2023 23:58

Alliance Global Partners analyst James Molloy reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment